AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger

AbbVie and Allergan are closer to completing the $63 billion merger of the two companies. On Tuesday, the companies announced they entered into a consent decree agreement with the Federal Trade Commission that commits them to a previously announced divestiture of products ahead of the merger.